Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | GLSI | KROS | ||
| Company | Acelyrin Inc | Greenwich Lifesciences Inc | Keros Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.24 | 18.77 | 11.15 | ||
| High | 2.36 | 18.94 | 11.16 | ||
| Low | 2.20 | 14.25 | 10.58 | ||
| Last | 2.27 | 15.67 | 11.03 | ||
| Change | +0.04 | -3.06 | -0.20 | ||
| Percent Change | +1.79% | -16.34% | -1.78% | ||
| Volume | 4,076,500 | 372,200 | 328,200 | ||
| 20-Day Average Volume | 1,091,300 | 133,255 | 223,600 | ||
| Previous | 2.23 | 18.73 | 11.23 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.33 | 16.24 | 10.77 | ||
| 20-Day Raw Stochastic | 45.16% | 38.54% | 66.34% | ||
| 20-Day Relative Strength | 47.29 | 45.28 | 52.02 | ||
| Weighted Alpha | -28.45 | -20.12 | -31.62 | ||
| Today's Opinion | 88% Sell | 72% Sell | 32% Sell | ||
| Yesterday's Opinion | 88% Sell | 40% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.61% since 05/13/25 | -6.00% since 08/21/26 | unch since 08/21/26 | ||
| Low | 1.95 on 05/15/25 | 14.25 on 08/28/26 | 10.58 on 08/28/26 | ||
| High | 2.36 on 05/20/25 | 19.64 on 08/25/26 | 11.71 on 08/25/26 | ||
| 1-Month | |||||
| %Chg | +3.18% since 04/17/25 | +16.51% since 07/28/26 | +9.53% since 07/28/26 | ||
| Low | 1.95 on 05/15/25 | 12.59 on 07/29/26 | 9.69 on 08/04/26 | ||
| High | 2.65 on 05/01/25 | 19.64 on 08/25/26 | 11.71 on 08/25/26 | ||
| 3-Month | |||||
| %Chg | +4.61% since 02/20/25 | -45.95% since 05/28/26 | -3.16% since 05/28/26 | ||
| Low | 1.95 on 05/15/25 | 12.51 on 07/24/26 | 9.69 on 08/04/26 | ||
| High | 2.94 on 04/02/25 | 29.93 on 06/01/26 | 12.19 on 07/10/26 | ||
| 6-Month | |||||
| %Chg | -48.76% since 11/20/24 | -43.47% since 02/27/26 | -22.27% since 02/27/26 | ||
| Low | 1.85 on 02/11/25 | 12.51 on 07/24/26 | 9.69 on 08/04/26 | ||
| High | 5.03 on 11/25/24 | 30.26 on 04/17/26 | 14.37 on 03/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 229,166 | 230,004 | 218,692 | ||
| Shares Outstanding, K | 100,954 | 14,678 | 19,827 | ||
| Annual Sales, $M | 0 | 0 | 244,060,000 | ||
| Annual Net Income, $M | -248,230,000 | -19,360,000 | 87,010,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 370,000 | ||
| Last Qtr Income, $M | -55,260,000 | -3,950,000 | -23,710,000 | ||
| 60-Month Beta | 1.07 | 1.46 | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 05/14/25 | -0.27 on 08/11/26 | -1.45 on 08/03/26 | ||
| Latest Earnings Date | 08/12/25 | 11/13/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||